市場調査レポート

欧州の血液銀行市場:フランス、ドイツ、イタリア、スペイン、英国

European Blood Banking Market 2014: France, Germany, Italy, Spain, UK Innovations, Trends and Opportunities for Suppliers

発行 Venture Planning Group 商品コード 263623
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。

Local License: 同一事業所内

Back to Top
欧州の血液銀行市場:フランス、ドイツ、イタリア、スペイン、英国 European Blood Banking Market 2014: France, Germany, Italy, Spain, UK Innovations, Trends and Opportunities for Suppliers
出版日: ページ情報: 英文
概要

当レポートでは、欧州の主要国(フランス、ドイツ、イタリア、スペイン、英国)における血液銀行市場について調査分析し、将来的なマーケティングと技術的な動向に焦点を当てて、検査件数の予測、装置の設置と販売台数、主要装置の機能比較、主要/新興の競合企業のプロファイルなどを提供して、概略以下の構成でお届けいたします。

第1章 イントロダクション

第2章 世界の技術・市場概要

  • 主な血液型・分類・感染症スクリーニング検査
  • 検査装置レビュー:主な自動/半自動分析装置の操作性・機能・販売価格
  • 主な体外診断技術とその潜在的応用

第3章 フランス

第4章 ドイツ

第5章 イタリア

第6章 スペイン

第7章 英国

第8章 主な製品開発の機会

第9章 代替的な市場普及戦略

第10章 潜在的な市場参入障壁とリスク

第11章 競合企業の評価

第12章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPBB4180-2-3

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.

European Blood Banking Market 2014: France, Germany, Italy, Spain, UK Innovations, Trends and Opportunities for Suppliers” is a new five-country strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. 

Rationale

During the next five years, the European blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition.  Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. 

The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Strategic Recommendations

- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.

Geographic Coverage

France, Germany, Italy, Spain, UK

The report explores future marketing and technological trends in Europe; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,
Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s),
Antiglobulin (Direct, C3 + IgG, IgG,  C3),
Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,
Hepatitis (HAV NAT, HBV NAT, HBs Ag,  
Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT,
Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis

Sales and market share estimates of leading
suppliers of blood banking of reagents
and instruments, by country and individual
product.

Competitive Assessments

Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new
products in R&D.

Market Segmentation Analysis

- Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth,
and key suppliers by country.

- Test volume and sales forecasts for over 40
blood banking tests, including NAT, by country and market segment:

- Blood Centers
- Hospitals
- Commercial/Private Laboratories

Current and Emerging Products

- Analysis of current and emerging blood banking tests.

- Review of automated and semi-automated
analyzers, including their operating
characteristics, features, and selling prices.

Technology Review

- Assessment of current and emerging technologies,
and their potential applications for the blood banking market.

- Comprehensive lists of companies developing
or marketing new technologies and products by test.

Contains 600 pages and 170 tables

Table of Contents

I.       Introduction

II.      Worldwide Technology and Market Overview

          A.  Major Blood Typing, Grouping
                and Infectious Disease Screening Tests

          B.  Instrumentation Review: Operating Characteristics, Features and Selling Prices
                of Leading Automated and Semiautomated Analyzers

          C.  Major In Vitro Diagnostic Technologies
                and Their Potential Applications

III.     France

IV.     Germany

V.      Italy

VI.     Spain
 

VII.    U.K.

VIII.   Major Product Development Opportunities

IX.     Alternative Market Penetration Strategies

X.      Potential Market Entry Barriers and Risks

XI.     Competitive Assessments

XII.    Appendix

Contains 600 pages and 170 tables

Back to Top